'Not just a space potato': Nasa unveils 'astonishing' details of most distant object ever visited
It ’s red, it’s cold, it’s 4bn years old: Nasa data from Arrokoth reveals ‘profound truths’ about the solar systemNasa has unveiled details of the most distant object visited by a spacecraft, in observations that could resolve a decades-long puzzle of how the planets first emerged from the hazy dust of the early solar system.The ultra-red, peanut-shaped object, called Arrokoth, sits located 1bn miles beyond Pluto in the Kuiper belt, a vast donut-shaped region that is home to thousands of dwarf planets and icy objects. Nasa ’s New Horizons spacecraft made a flyby on New Year’s Day 2...
Source: Guardian Unlimited Science - February 13, 2020 Category: Science Authors: Hannah Devlin Science correspondent Tags: Nasa Space Astronomy Science Source Type: news

Palforzia ([Peanut (arachis hypogaea) Allergen Powder-dnfp] Powder for Oral Administration) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - February 12, 2020 Category: Drugs & Pharmacology Source Type: news

Miracle drug could 'cure' peanut allergies within weeks
Scientists who developed the drug predict some patients may need only a single treatment to end the peanut allergy altogether, while others may need a top-up jab every few months to keep it at bay. (Source: the Mail online | Health)
Source: the Mail online | Health - February 11, 2020 Category: Consumer Health News Source Type: news

First Peanut Allergy Drug Gets FDA Thumbs Up
Palforzia is now approved for use in individuals aged 4 through 17 who have a confirmed diagnosis of peanut allergy. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 6, 2020 Category: Pharmaceuticals Authors: Dana Dovey, Contributor Source Type: news

Nestle Invests $200 Mln More in Aimmune After Peanut Allergy Drug Approval Nestle Invests $200 Mln More in Aimmune After Peanut Allergy Drug Approval
Aimmune Therapeutics Inc said on Wednesday the health science arm of Nestle SA will invest an additional $200 million in the drugmaker, bringing the Swiss company's total investment to $473 million.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 6, 2020 Category: Consumer Health News Tags: Family Medicine/Primary Care News Source Type: news

U.S. FDA approves first treatment for kids with peanut allergy
The first treatment for peanut allergies is about to hit the market in the U.S., a big step toward better care for all kinds of food allergies — but still a long way from a cure. (Source: CBC | Health)
Source: CBC | Health - February 5, 2020 Category: Consumer Health News Tags: News/Health Source Type: news

First Drug Approved for Treatment of Peanut Allergy in Children
Title: First Drug Approved for Treatment of Peanut Allergy in ChildrenCategory: Health NewsCreated: 2/3/2020 12:00:00 AMLast Editorial Review: 2/4/2020 12:00:00 AM (Source: MedicineNet Allergies General)
Source: MedicineNet Allergies General - February 4, 2020 Category: Allergy & Immunology Source Type: news

Breakthrough treatment for peanut allergies in children approved for use in the US 
The drug AR101 has been approved as a treatment for peanut allergies in the US. It won't cure the allergy but reduce the severity of a reaction to peanuts. It should not be used instead of an EpiPen. (Source: the Mail online | Health)
Source: the Mail online | Health - February 3, 2020 Category: Consumer Health News Source Type: news

First Treatment for Peanut Allergy Approved by FDA
Palforzia is not a cure, youngsters using the treatment still must avoid peanuts, and protection is lost if they stop taking the powder daily. (Source: WebMD Health)
Source: WebMD Health - February 3, 2020 Category: Consumer Health News Source Type: news

FDA Approves First Drug To Treat Peanut Allergies In Children
(CNN) — The US Food and Drug Administration approved the first drug to treat peanut allergies in children on Friday, following an advisory committee vote of approval in September. The drug, Palforzia, can be used for children between 4 and 17 years old. It’s designed to minimize the incidence and severity of a child’s allergic reaction to peanuts, as even a small amount of exposure can be harmful to children with the allergy. Children are left attempting to avoid exposure to peanuts to avoid reactions. Though that will continue to be necessary with Palforzia, the risk of a reaction will be lessened, says ...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - February 3, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Syndicated CBSN Boston CNN Peanut Allergy Source Type: news

Palforzia Approved for Treatment of Peanut Allergy in Children
MONDAY, Feb. 3, 2020 -- The U.S. Food and Drug Administration approved Palforzia (Peanut [Arachis hypogaea] Allergen Powder-dnfp) to alleviate allergic reactions to accidental peanut exposure, the agency announced late Friday. Palforzia, a powder... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 3, 2020 Category: General Medicine Source Type: news

Health Highlights: Feb. 3, 2020
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: First Treatment for Peanut Allergy Approved by FDA The first treatment for peanut allergy has been approved by the U.S. Food and Drug... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 3, 2020 Category: General Medicine Source Type: news

First Treatment for Peanut Allergy Approved by FDA
Title: First Treatment for Peanut Allergy Approved by FDACategory: Health NewsCreated: 2/3/2020 12:00:00 AMLast Editorial Review: 2/3/2020 12:00:00 AM (Source: MedicineNet Allergies General)
Source: MedicineNet Allergies General - February 3, 2020 Category: Allergy & Immunology Source Type: news

Peanut allergy drug approved by the US FDA
The drug is aimed at protecting against accidental exposure, but may cause a fatal reaction. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - February 1, 2020 Category: Consumer Health News Source Type: news

FDA approves first drug to treat peanut allergies in children
The US Food and Drug Administration on Friday approved Palforzia, the very first drug to treat peanut allergies in children. (Source: CNN.com - Health)
Source: CNN.com - Health - February 1, 2020 Category: Consumer Health News Source Type: news

FDA OKs Palforzia, First Drug for Peanut Allergy in Children FDA OKs Palforzia, First Drug for Peanut Allergy in Children
Palforzia will carry a boxed warning on the risk of anaphylaxis, and initial doses can be given only by certified professionals in certified settings.FDA Approvals (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - February 1, 2020 Category: Allergy & Immunology Tags: Allergy & Clinical Immunology News Alert Source Type: news

FDA approves first peanut allergy treatment
Patients swallow a trace amount of peanut protein and gradually scale up. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - February 1, 2020 Category: Consumer Health News Source Type: news

FDA approves first peanut allergy treatment for children
The FDA has approved the first treatment to treat peanut allergies, which can be deadly. Kids swallow peanut powder, at first in tiny, then in increasingly larger doses. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - February 1, 2020 Category: Consumer Health News Source Type: news

Peanut allergy drug from Peninsula company approved by FDA
Aimmune Therapeutics Inc. ended a nearly nine-year quest Friday by winning Food and Drug Administration for a first-of-its-kind peanut allergy treatment that protects people from potentially lethal accidental exposures. The oral immunotherapy, a capsule of powderized peanut protein called Palforzia, is approved for kids ages 4-17 — a group whose parents kickstarted the Brisbane company's founding in 2011 after a venting meeting with clinicians, advocacy groups, regulators and drug developers. "They… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 1, 2020 Category: Biotechnology Authors: Ron Leuty Source Type: news

Treating Peanut Allergy: Insights From an Insider Treating Peanut Allergy: Insights From an Insider
Why all the hype about oral immunotherapy for peanut allergy? Dr Jonathan Spergel, an investigator in the clinical trials, shares his insights.CHOP Expert Commentary (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - February 1, 2020 Category: Allergy & Immunology Tags: Pediatrics Expert Interview Source Type: news

First peanut allergy drug approved by FDA
The treatment can prevent life-threatening allergies caused by accidental exposures to peanuts. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - February 1, 2020 Category: Consumer Health News Authors: Carolyn Y. Johnson Source Type: news

FDA approves first treatment for kids with peanut allergy
The Food and Drug Administration has approved the first treatment for children with peanut allergies (Source: ABC News: Health)
Source: ABC News: Health - February 1, 2020 Category: Consumer Health News Tags: Health Source Type: news

Peanut allergy drug from Peninsula company approved by FDA
Aimmune Therapeutics Inc. ended a nearly nine-year quest Friday by winning Food and Drug Administration for a first-of-its-kind peanut allergy treatment that protects people from potentially lethal accidental exposures. The oral immunotherapy, a capsule of powderized peanut protein called Palforzia, is approved for kids ages 4-17 — a group whose parents kickstarted the Brisbane company's founding in 2011 after a venting meeting with clinicians, advocacy groups, regulators and drug developers. "They… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 1, 2020 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

Peanut allergy: substantial disease burden in the US
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - February 1, 2020 Category: Drugs & Pharmacology Source Type: news

FDA approves first drug for treatment of peanut allergy for children
Today the U.S. Food and Drug Administration approved Palforzia [Peanut (Arachis hypogaea) Allergen Powder-dnfp] to mitigate allergic reactions, including anaphylaxis, that may occur with accidental exposure to peanuts. Treatment with Palforzia may be initiated in individuals ages 4 through 17 years with a confirmed diagnosis of peanut allergy and may be continued in individuals 4 years of age and older. (Source: World Pharma News)
Source: World Pharma News - January 31, 2020 Category: Pharmaceuticals Tags: Featured FDA Regulatory Affairs Source Type: news

FDA Approves Palforzia [Peanut (Arachis hypogaea) Allergen Powder-dnfp] as First Treatment for Peanut Allergy
BRISBANE, Calif.--(BUSINESS WIRE)--Jan. 31, 2020-- Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing and commercializing treatments for potentially life-threatening food allergies, today announced that the U.S. Food... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - January 31, 2020 Category: Drugs & Pharmacology Source Type: news

Is peanut sensitisation screening cost effective in high-risk infants?
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - January 1, 2020 Category: Drugs & Pharmacology Source Type: news

Scientists investigate resveratrol's anti-hypertension properties
(Natural News) Your cardiovascular system will appreciate all of the blueberries, peanuts, red grapes, and red wine in your diet. The foods contain resveratrol, a natural compound that helps normalize blood pressure. Studies have already uncovered many other health benefits of resveratrol. It protects nerve cells against the aging process and may reduce the risk... (Source: NaturalNews.com)
Source: NaturalNews.com - December 31, 2019 Category: Consumer Health News Source Type: news

Many With Peanut Allergies Unnecessarily Avoid Tree Nuts
MONDAY, Dec. 30, 2019 -- Individual tree nuts have unique characteristics in the context of peanut allergy, so dietary recommendations should reflect these differences, according to a study published online Dec. 2 in the Annals of Allergy, Asthma... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 30, 2019 Category: Pharmaceuticals Source Type: news

Sacla', Waitrose and Aldi pesto products recalled over peanut fears
The affected products include the brand Sacla' as well as supermarkets Waitrose and Aldi. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - December 21, 2019 Category: Consumer Health News Source Type: news

Forty percent of people with peanut allergies can eat tree nuts but choose not to
(American College of Allergy, Asthma, and Immunology) New study showed that nearly 90% of people with peanut allergy could potentially tolerate almonds, but 33% of that group preferred strict avoidance due to fear of an allergic reaction. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 18, 2019 Category: International Medicine & Public Health Source Type: news

Multi-omics approach offers new insights into peanut allergy severity
(The Mount Sinai Hospital / Mount Sinai School of Medicine) Researchers at the Icahn School of Medicine at Mount Sinai have identified novel genes associated with the severity of peanut allergy, as well as ways in which these genes interact with other genes during allergic reactions. The findings, published December 12 in the Journal of Allergy and Clinical Immunology, could lead to better treatments for peanut allergy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 13, 2019 Category: International Medicine & Public Health Source Type: news

Medical News Today: Can peanut butter affect weight gain?
Peanut butter is high in protein and high in fat, but will it make you gain weight? Read this article to learn how peanut butter affects your weight. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 11, 2019 Category: Consumer Health News Tags: Nutrition / Diet Source Type: news

Peanut allergy vaccine to rewrite the immune system
(University of South Australia) Peanut allergies could become a thing of the past as breakthrough research from the University of South Australia develops a radically novel vaccination that's poised to cure the potentially life threatening condition. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 6, 2019 Category: International Medicine & Public Health Source Type: news

Feeding peanuts to babies from three months 'could protect them from allergies' 
High-risk babies introduced to foods at three months had a 14% lower chance of getting an allergy than those introduced at six months, study led by King's College London found. (Source: the Mail online | Health)
Source: the Mail online | Health - December 4, 2019 Category: Consumer Health News Source Type: news

Introducing peanuts and eggs early can prevent food allergies in high risk infants
(King's College London) Research undertaken by King's College London and St George's, University of London has found that introducing certain foods early to infants can prevent them from developing an allergy despite low adherence to an introduction regime. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 4, 2019 Category: International Medicine & Public Health Source Type: news

Is Peanut Oral Immunotherapy Too Risky? Is Peanut Oral Immunotherapy Too Risky?
A recent study found that peanut OIT was associated with increased risk for anaphylaxis and serious adverse events, but the analysis leaves out some important considerations, says Dr Brian Vickery.Medscape Allergy & Immunology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 26, 2019 Category: Consumer Health News Tags: Allergy & Clinical Immunology Commentary Source Type: news

Peanut Allergy Healthcare Costs High Peanut Allergy Healthcare Costs High
Nut allergy is a significant burden on the healthcare system, new research confirms, but immunotherapies on the horizon might reduce that.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 21, 2019 Category: Consumer Health News Tags: Allergy & Clinical Immunology News Source Type: news

Medical News Today: What to know about nut allergies
Tree nut allergies are common, and they include reactions to almonds, cashews, and walnuts. An allergy to peanuts is not technically a nut allergy. Learn more about nut allergies here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 18, 2019 Category: Consumer Health News Tags: Food Allergy Source Type: news

Medical News Today: New injection halts peanut allergy for at least 2 weeks
One antibody injection allowed 11 of 15 adults with severe peanut allergy to eat a small amount of nut protein 15 days later with no allergic reaction. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 18, 2019 Category: Consumer Health News Tags: Food Allergy Source Type: news

An injection could someday keep peanut allergies at bay for up to six weeks, study says
More than 3 million people in the United States are allergic to peanuts and tree nuts. But experimental new research suggests adults might someday be able to take an antibody to keep symptoms at bay for up to six weeks -- at least in small doses. (Source: CNN.com - Health)
Source: CNN.com - Health - November 16, 2019 Category: Consumer Health News Source Type: news

Experimental Injection May Block Peanut Allergy
Just one shot of an experimental antibody treatment allowed people with severe peanut allergy to eat about one peanut's worth of peanut protein two weeks later, the study found. (Source: WebMD Health)
Source: WebMD Health - November 14, 2019 Category: Consumer Health News Source Type: news

A single injection of an antibody treatment 'can protect peanut allergy sufferers for a fortnight'
Researchers from Stanford University in California, found almost three quarters of people who had the injection could eat the equivalent of an entire nut a fortnight later. (Source: the Mail online | Health)
Source: the Mail online | Health - November 14, 2019 Category: Consumer Health News Source Type: news

Experimental Injection May Protect Against Peanut Allergy
THURSDAY, Nov. 14, 2019 -- People with peanut allergy must be constantly vigilant to avoid a life-threatening allergic reaction. But researchers report that a new drug injection might offer at least temporary protection against the most severe... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 14, 2019 Category: General Medicine Source Type: news

Experimental Injection May Protect Against Peanut Allergy
Title: Experimental Injection May Protect Against Peanut AllergyCategory: Health NewsCreated: 11/14/2019 12:00:00 AMLast Editorial Review: 11/14/2019 12:00:00 AM (Source: MedicineNet Allergies General)
Source: MedicineNet Allergies General - November 14, 2019 Category: Allergy & Immunology Source Type: news

Top 10 Medical Innovations for 2020, According to Cleveland Clinic Top 10 Medical Innovations for 2020, According to Cleveland Clinic
A new osteoporosis drug, minimally invasive mitral valve surgery, immunotherapy for peanut allergies, and biologics in orthopedic repair are among the advances predicted to have the greatest impact in 2020.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 7, 2019 Category: Consumer Health News Tags: Family Medicine/Primary Care News Source Type: news

November 2019
Medical Scans Explained : A Look Inside the Body Yoga for Health : Positioning Your Body and Mind Healthy Eating Special Issue Peanut Allergy Therapy Loses Effect After Stopping Taking Control of Your Mental Health (Source: NIH News in Health)
Source: NIH News in Health - October 30, 2019 Category: Consumer Health News Source Type: news

Peanut-allergy therapy 'protection not a cure'
Immunotherapy works by suppressing the allergic response, rather than curing it, a study suggests. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - October 30, 2019 Category: Consumer Health News Source Type: news

Peanut allergy treatment does not CURE patients but protects them from reactions, scientists say
King's College London scientists were able to reduce patients' sensitivity to the nut using immunotherapy pills, but they could not get rid of the allergy altogether. (Source: the Mail online | Health)
Source: the Mail online | Health - October 30, 2019 Category: Consumer Health News Source Type: news

Halloween Can Be Frightful for Kids With Allergies, Asthma
SATURDAY, Oct. 26, 2019 -- Allergies and asthma can turn Halloween into fright night, so parents must be vigilant. Some fun-sized candy bars have no labels to alert about possible food allergens, such as peanuts, said Dr. Todd Mahr, president of the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 26, 2019 Category: General Medicine Source Type: news